Regular epilation regimen only for Pilonidal Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Stanford University School of Medicine, Palo Alto, CA
Pilonidal Disease
Regular Epilation Regimen - Procedure
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

The goal is to evaluate whether surgical excision of the pilonidal disease is needed after resolution of the initial symptoms when the patient follows regular hair removal regimen such as laser epilation.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: Up to 1 year

Baseline to 1 year
Effect on parent's daily activities
Up to 1 year
Number of participants requiring additional surgical intervention
Number of participants requiring antibiotic treatment
Number of participants with recurrent symptoms of pilonidal disease
Time taken off from school or work due to pilonidal disease

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Regular epilation regimen only
1 of 2
Regular epilation regimen with surgical excision
1 of 2
Active Control

400 Total Participants · 2 Treatment Groups

Primary Treatment: Regular epilation regimen only · No Placebo Group · N/A

Regular epilation regimen only
Procedure
ActiveComparator Group · 1 Intervention: Regular Epilation Regimen · Intervention Types: Procedure
Regular epilation regimen with surgical excisionActiveComparator Group · 2 Interventions: Regular Epilation Regimen, Surgical excision · Intervention Types: Procedure, Procedure

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 1 year
Closest Location: Stanford University School of Medicine · Palo Alto, CA
Photo of california 1Photo of california 2Photo of california 3
2010First Recorded Clinical Trial
1 TrialsResearching Pilonidal Disease
673 CompletedClinical Trials

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,130 Previous Clinical Trials
35,668,510 Total Patients Enrolled
Bill Chiu, MDPrincipal InvestigatorStanford University

Eligibility Criteria

Age Any Age · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are over the age of 8 years.\n

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.